Analyst Ratings for Protagonist Therapeutics (PTGX)
PTGX Rating Summary
PTGX Price Target Summary
- Highest: $118.00 (Jefferies)
- Lowest: $73.00 (Leerink Partners)
- Average: $103.92
* Over Last 12-Mos
Overall Rating:
BUY
Rating Trend:
Avg. $ Target:
$103.92 (+12.8%)
* Over Last 12-Mos
Rating Score: 10 / 10
Percentile Rank: 95%
Avg. $ Target:
$103.92 (+12.8%)
* Over Last 12-Mos
Rating Score: 10 / 10
Percentile Rank: 95%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 9/17/2025 | Barclays » Updated 2/26/2026 |
Etzer Darout | New Coverage | Overweight (N/A) |
113.00 (108.00) |
0.00 (92.09) |
0% | Details |
| 9/12/2025 | Leerink Partners | Faisal Khurshid | New Coverage | Outperform (N/A) |
73.00 (N/A) |
59.68 (92.09) |
54.31% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
